BioSyntech, Inc.
BSYI · OTC
3/31/2009 | 3/31/2008 | 3/31/2007 | 3/31/2006 | |
|---|---|---|---|---|
| Revenue | $41 | $274 | $243 | $62 |
| % Growth | -85.1% | 12.5% | 295.9% | – |
| Cost of Goods Sold | $16 | $102 | $470 | $21 |
| Gross Profit | $25 | $172 | $154 | $40 |
| % Margin | 60.8% | 62.8% | 63.1% | 65.2% |
| R&D Expenses | $5,800 | $6,024 | $4,958 | $3,203 |
| G&A Expenses | $3,007 | $0 | $0 | $0 |
| SG&A Expenses | $3,007 | $3,669 | $3,838 | $2,911 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2,248 | -$322 | -$309 | $291 |
| Operating Expenses | $11,055 | $9,371 | $7,728 | $6,405 |
| Operating Income | -$11,030 | -$9,199 | -$7,295 | -$6,365 |
| % Margin | -27,056.3% | -3,358% | -2,996.2% | -10,349% |
| Other Income/Exp. Net | $11,030 | -$51 | $829 | $6,365 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$12,939 | -$9,269 | -$8,114 | -$6,855 |
| % Margin | -31,739.1% | -3,383.8% | -3,332.4% | -11,145.5% |
| EPS | -0.13 | -0.1 | -0.09 | -0.17 |
| % Growth | -30% | -11.1% | 47.1% | – |
| EPS Diluted | -0.13 | -0.1 | -0.09 | -0.17 |
| Weighted Avg Shares Out | 95,902 | 95,487 | 94,195 | 40,937 |
| Weighted Avg Shares Out Dil | 95,902 | 95,487 | 94,195 | 40,937 |
| Supplemental Information | – | – | – | – |
| Interest Income | $141 | $323 | $0 | $72 |
| Interest Expense | $256 | $381 | $0 | $607 |
| Depreciation & Amortization | $413 | $452 | $445 | $468 |
| EBITDA | -$10,617 | -$8,759 | -$7,890 | -$5,806 |
| % Margin | -26,043.2% | -3,197.6% | -3,240.5% | -9,439.7% |